Fadi Haddad: Hyperleukocytosis in Acute myeloid leukemia

Fadi Haddad, Assistant Professor at Leukemia Department at MD Anderson Cancer Center, shared a post on X about a recent paper titled “Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis” published in the JCO Oncology Practice.

Authors: Fadi G. Haddad, Koji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace Park, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A. Abbas, Nicholas J. Short, Naval Daver, Elias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Kadia.

“Out in ASCO’s JCO Oncology Practice Hyperleukocytosis in AML (acute myeloid leukemia)

People: N=129, WBC>100K
MVA = older age, leukostasis, platelets <40 leads to Higher early mortality

• ICU admission needed
• Cytoreductive therapy at measured dosing could reduce complications.”

Source: Fadi Haddad/X